Blueberries Medical Corp. (CSE:BBM)
Canada · Delayed Price · Currency is CAD 0.0100
0.00 (0.00%)
Jun 5, 2026, 9:30 AM EST
Blueberries Medical Income Statement
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
| 0.3 | 0.31 | 0.47 | 0.29 | 0.24 | 0.14 | |
Revenue Growth (YoY) | -31.51% | -33.76% | 63.53% | 22.43% | 69.70% | 110.29% |
Cost of Revenue | 0.15 | 0.16 | 0.31 | 0.2 | 0.25 | 0.38 |
Gross Profit | 0.15 | 0.15 | 0.16 | 0.08 | -0.02 | -0.25 |
Selling, General & Admin | 0.79 | 1.36 | 0.94 | 1.29 | 1.36 | 0.67 |
Operating Expenses | 0.92 | 1.53 | 1.08 | 1.46 | 1.62 | 1.54 |
Operating Income | -0.77 | -1.38 | -0.91 | -1.38 | -1.64 | -1.79 |
Interest Expense | - | - | - | -0.26 | -0.36 | -0.27 |
Currency Exchange Gain (Loss) | -0.02 | -0.02 | -0.07 | 0.15 | -0.12 | -0.17 |
Other Non Operating Income (Expenses) | 0.02 | 0.02 | 0 | 0.02 | 0.51 | 0.38 |
EBT Excluding Unusual Items | -0.77 | -1.38 | -0.98 | -1.47 | -1.61 | -1.84 |
Gain (Loss) on Sale of Investments | - | - | - | - | - | -0.57 |
Gain (Loss) on Sale of Assets | - | - | -0.17 | 0.02 | 0.02 | - |
Asset Writedown | -0.29 | -0.29 | - | -0.18 | - | -2.82 |
Other Unusual Items | - | - | - | - | 0.13 | 0.09 |
Pretax Income | -1.06 | -1.67 | -1.15 | -1.64 | -1.47 | -5.15 |
Net Income | -1.06 | -1.67 | -1.15 | -1.64 | -1.47 | -5.15 |
Net Income to Common | -1.06 | -1.67 | -1.15 | -1.64 | -1.47 | -5.15 |
Shares Outstanding (Basic) | 495 | 473 | 399 | 219 | 169 | 149 |
Shares Outstanding (Diluted) | 495 | 473 | 399 | 219 | 169 | 149 |
Shares Change (YoY) | 23.66% | 18.53% | 81.95% | 29.85% | 13.73% | 19.83% |
EPS (Basic) | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 |
EPS (Diluted) | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.03 |
Free Cash Flow | -0.42 | -1.24 | -0.8 | -1.35 | -1.47 | -1.69 |
Free Cash Flow Per Share | -0.00 | -0.00 | -0.00 | -0.01 | -0.01 | -0.01 |
Gross Margin | 50.61% | 47.34% | 34.90% | 29.22% | -7.53% | -176.91% |
Operating Margin | -257.68% | -441.57% | -193.70% | -477.44% | -696.79% | -1289.55% |
Profit Margin | -352.85% | -533.44% | -243.64% | -567.30% | -623.44% | -3709.64% |
Free Cash Flow Margin | -139.25% | -398.06% | -169.03% | -470.00% | -623.72% | -1217.90% |
EBITDA | -0.7 | -1.28 | -0.81 | -1.23 | -1.35 | -1.08 |
EBITDA Margin | -233.10% | - | -171.38% | - | - | - |
D&A For EBITDA | 0.07 | 0.1 | 0.11 | 0.15 | 0.29 | 0.7 |
EBIT | -0.77 | -1.38 | -0.91 | -1.38 | -1.64 | -1.79 |
EBIT Margin | -257.68% | - | -193.70% | - | - | - |